Jiangsu Hengrui Medicine Co., Shanghai Hengrui Pharmaceutical Co. patent factor XIa inhibitors March 27, 2018 No Comments
Positive topline data from phase III study of ALXN-1210 in patients with PNH March 16, 2018 No Comments
RSS